Prelude Therapeutics Ownership | Who Owns Prelude Therapeutics?
Prelude Therapeutics Ownership Summary
Prelude Therapeutics is owned by 35.74% institutional investors, 9.93% insiders, and 54.32% retail investors. Orbimed advisors is the largest institutional shareholder, holding 14.36% of PRLD shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 1.31% of its assets in Prelude Therapeutics shares.
PRLD Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Prelude Therapeutics | 35.74% | 9.93% | 54.32% |
| Sector | Healthcare Stocks | 42.54% | 10.83% | 46.63% |
| Industry | Biotech Stocks | 45.22% | 10.75% | 44.04% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Orbimed advisors | 10.91M | 14.36% | $15.71M |
| Baker bros. advisors lp | 10.12M | 13.32% | $14.58M |
| Boxer capital | 2.57M | 3.39% | $9.79M |
| Blackrock | 1.07M | 1.41% | $4.07M |
| Vanguard group | 992.85K | 1.31% | $1.43M |
| Price t rowe associates inc /md/ | 876.34K | 1.15% | $1.26M |
| Renaissance | 544.00K | 0.72% | $783.36K |
| Acadian asset management | 540.57K | 0.71% | $777.00K |
| Millennium management | 462.56K | 0.61% | $589.76K |
| Morgan stanley | 284.20K | 0.37% | $409.25K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Boxer capital | 2.57M | 0.52% | $9.79M |
| Orbimed advisors | 10.91M | 0.37% | $15.71M |
| Baker bros. advisors lp | 10.12M | 0.11% | $14.58M |
| Shay capital | 100.00K | 0.01% | $144.00K |
| Gsa capital partners llp | 75.16K | 0.01% | $108.00K |
| Bridgeway capital management | 53.50K | 0.00% | $77.04K |
| Acadian asset management | 540.57K | 0.00% | $777.00K |
| Xtx topco | 15.58K | 0.00% | $22.43K |
| Renaissance | 544.00K | 0.00% | $783.36K |
| Two sigma advisers, lp | 222.70K | 0.00% | $320.69K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Millennium management | 462.56K | 0.00% | 302.03K |
| Susquehanna group, llp | 72.80K | - | 72.80K |
| Vanguard group | 992.85K | - | 60.28K |
| Prudential financial | 25.84K | - | 25.84K |
| Shay capital | 100.00K | 0.01% | 25.00K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Deerfield management company, l.p. (series c) | - | - | -3.77M |
| Exoduspoint capital management, lp | - | - | -921.62K |
| Avidity partners management lp | - | - | -890.00K |
| Massachusetts financial services co /ma/ | - | - | -494.50K |
| Sio capital management | - | - | -320.39K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Susquehanna group, llp | 72.80K | - | 72.80K | $92.82K |
| Prudential financial | 25.84K | - | 25.84K | $37.21K |
| Hrt financial lp | 16.90K | 0.00% | 16.90K | $24.00K |
| Aqr capital management | 12.49K | - | 12.49K | $15.93K |
| Optiver b.v. | 20.00 | - | 20.00 | $29.00 |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -1.00 |
| Capital performance advisors llp | -8.00 |
| True wealth design | -13.00 |
| Highmark wealth management | -50.00 |
| Russell investments group | -76.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 44 | -2.22% | 27,161,948 | 1.82% | 35 | 2.90% | 15 | -11.76% | 18 | -14.29% |
| Jun 30, 2025 | 49 | -14.04% | 27,188,001 | -4.17% | 35 | 2.57% | 19 | -9.52% | 23 | -4.17% |
| Mar 31, 2025 | 57 | -6.56% | 30,474,260 | -5.26% | 40 | 2.23% | 22 | -35.29% | 24 | 118.18% |
| Dec 31, 2024 | 22 | -69.01% | 4,265,950 | -88.07% | 5 | 0.25% | 12 | -67.57% | 4 | -78.95% |
| Sep 30, 2024 | 71 | 14.52% | 35,754,682 | 5.42% | 47 | 2.35% | 37 | 48.00% | 19 | -9.52% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard US Total Market Shares ETF | 720.43K | 1.31% | - |
| Vanguard Total Stock Mkt Idx Inv | 705.02K | 1.25% | -15.41K |
| T. Rowe Price Health Sciences | 653.96K | 1.16% | -7.26K |
| Biotech Growth Ord | 346.50K | 0.61% | - |
| MFS New Discovery I | 327.70K | 0.60% | - |
| T. Rowe Price Small-Cap Value | 168.61K | 0.31% | -90.00 |
| Fidelity Small Cap Index | 144.77K | 0.26% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 142.55K | 0.25% | -64.96K |
| MFS VIT New Discovery Init | 104.99K | 0.19% | - |
| State St Russell Sm/Mid Cp® Indx NL Cl C | 104.70K | 0.19% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Mar 25, 2025 | Combs Andrew | Chief Chemistry Officer | Buy | $69.25K |
| Mar 25, 2025 | Vaddi Krishna | CEO | Buy | $467.44K |
| Mar 20, 2025 | Vaddi Krishna | CEO | Buy | $3.95K |
| Mar 21, 2025 | Vaddi Krishna | CEO | Buy | $10.96K |
| Mar 17, 2025 | Vaddi Krishna | CEO | Buy | $6.83K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | - | - |
| 2025 Q3 | - | - |
| 2025 Q2 | - | - |
| 2025 Q1 | 8 | - |
| 2024 Q4 | 7 | - |
PRLD Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools